These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29217742)

  • 1. Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas.
    Zakhari N; Taccone MS; Torres C; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Nguyen TB
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):260-264. PubMed ID: 29217742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Centrally Restricted Diffusion Sign in Cerebral Metastatic Disease: Differentiating Radiation Necrosis from Tumor Recurrence.
    Puac-Polanco P; Zakhari N; Miller J; McComiskey D; Thornhill RE; Jansen GH; Nair VJ; Nguyen TB
    Can Assoc Radiol J; 2023 Feb; 74(1):100-109. PubMed ID: 35848632
    [No Abstract]   [Full Text] [Related]  

  • 3. Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors.
    Matsunaga S; Shuto T; Takase H; Ohtake M; Tomura N; Tanaka T; Sonoda M
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):47-52. PubMed ID: 22541963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics.
    Razek AAKA; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
    Neuroradiology; 2018 Feb; 60(2):169-177. PubMed ID: 29218370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally Reduced Diffusion Sign for Differentiation between Treatment-Related Lesions and Glioma Progression: A Validation Study.
    Alcaide-Leon P; Cluceru J; Lupo JM; Yu TJ; Luks TL; Tihan T; Bush NA; Villanueva-Meyer JE
    AJNR Am J Neuroradiol; 2020 Nov; 41(11):2049-2054. PubMed ID: 33060101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for differentiation of glioma recurrence from radionecrosis using integrated
    Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
    Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Low- and High-Grade Gliomas Using High b-Value Diffusion Imaging with a Non-Gaussian Diffusion Model.
    Sui Y; Xiong Y; Jiang J; Karaman MM; Xie KL; Zhu W; Zhou XJ
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1643-9. PubMed ID: 27256851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and
    Qiao Z; Zhao X; Wang K; Zhang Y; Fan D; Yu T; Shen H; Chen Q; Ai L
    AJNR Am J Neuroradiol; 2019 Feb; 40(2):253-259. PubMed ID: 30655259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.
    Alkonyi B; Barger GR; Mittal S; Muzik O; Chugani DC; Bahl G; Robinette NL; Kupsky WJ; Chakraborty PK; Juhász C
    J Nucl Med; 2012 Jul; 53(7):1058-64. PubMed ID: 22653792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
    Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
    Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the utility of
    Crain ID; Elias PS; Chapple K; Scheck AC; Karis JP; Preul MC
    J Neurooncol; 2017 May; 133(1):97-105. PubMed ID: 28555423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery.
    Hainc N; Alsafwani N; Gao A; O'Halloran PJ; Kongkham P; Zadeh G; Gutierrez E; Shultz D; Krings T; Alcaide-Leon P
    J Neurooncol; 2021 Dec; 155(3):325-333. PubMed ID: 34689307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
    Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T
    Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous
    Jena A; Taneja S; Jha A; Damesha NK; Negi P; Jadhav GK; Verma SM; Sogani SK
    AJNR Am J Neuroradiol; 2017 May; 38(5):899-907. PubMed ID: 28341716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.
    Cihangiroglu MM; Ozturk-Isik E; Firat Z; Kilickesmez O; Ulug AM; Ture U
    Diagn Interv Imaging; 2017 Mar; 98(3):261-268. PubMed ID: 28038915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading Gliomas Capability: Comparison between Visual Assessment and Apparent Diffusion Coefficient (ADC) Value Measurement on Diffusion-Weighted Imaging (DWI).
    Phuttharak W; Thammaroj J; Wara-Asawapati S; Panpeng K
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):385-390. PubMed ID: 32102515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.